Use of Cell Lines in the Investigation of Pharmacogenetic Loci

Abstract

Drug response and toxicity, complex traits that are often highly varied among individuals, likely involve multiple genetic and non-genetic factors. Pharmacogenomic research aims to individualize therapy in an effort to maximize efficacy and minimize toxicity for each patient. Cell lines can be used as a model system for cellular pharmacologic effects, which include, but are not limited to, drug-induced cytotoxicity or apoptosis, biochemical effects and enzymatic reactions. Because severe toxicities may be associated with drugs such as chemotherapeutics, cell lines derived from healthy individuals or patients provide a convenient model to study how human genetic variation alters response to these drugs that would be unsafe or unethical to administer to human volunteers. In addition to the traditional candidate gene approaches that focus on well-understood candidate genes and pathways, the availability of extensive genotypic and phenotypic data on some cell line models has begun to allow genome-wide association (GWA) studies to simultaneously test the entire human genome for associations with drug response and toxicity. Though with some important limitations, the use of these cell lines in pharmacogenomic discovery demonstrates the promise of constructing a more comprehensive model that may ultimately integrate both genetic and non-genetic factors to predict individual response and toxicity to anticancer drugs.

Polymorphic Variation in TPMT Is the Principal Determinant of TPMT Phenotype: A Meta‐Analysis of Three Genome‐Wide Association Studies

“…13,14 Of note, LCLs but even non-HapMap LCLs have been promised as useful model systems for cellular pharmacologic effects as well as biochemical effects and enzymatic reactions. 25 Several studies have been reported using LCL resources including various whole-genome approaches (e.g. GWAS) to identify novel genetic variants which subsequently were associated with anticancer-related cytotoxicity (e.g.…”

Population differences in microRNA expression and biological implications

“…To date, genetic variants in the form of millions of single nucleotide polymorphisms (SNPs) and thousands of copy number variants (CNVs), transcription level gene expression and other phenotypic data (e.g., cellular sensitivity to drugs) have been made publicly available for many of the HapMap samples. 23,24 In this study, we set out to evaluate the extent of population differences in an important class of posttranscriptional regulators of gene expression, namely miRNAs. We explored the potential biological function of the observed differentially expressed miRNAs by comprehensively examining their relationship with target mRNAs and cellular sensitivity to chemotherapy.…”

Genome-wide Expression Profiling of Human Lymphoblastoid Cell Lines Identifies CHL1 as a Putative SSRI Antidepressant Response Biomarker

“…Epstein-Barr virus (EBV) immortalized human lymphoblastoid cell lines (LCLs) from unrelated individual donors are gaining popularity as a faithful representation for the inherent human genome and epigenome natural diversity [19]. These cell lines, which are generated from peripheral blood B lymphocytes, retain most of the phenotypic properties of B lymphocytes, including the production of antibodies.…”